User login

Get Benzinga's Best Trading Ideas For Free

MannKind Corporation (MNKD) 7.34 +0.05

Trade MNKD
NOW!
Last Trade:6.91Short Ratio:11.10
Last Trade Time:4:00pmDay Range:6.77 - 7.10
Ask:7.34Year Range:4.76 - 12.30
Bid:6.55One Year Target:10.00
Open:6.79Exchange:NGM
Volume:1114898EBITDA:-174.0M
Prev. Close:6.86Market Cap:784.0M
50 Day Moving:6.3436Div Yield:
200 day moving:7.4883PE:

Related RealMoney articles from TheStreet.com

'Mad Money Lightning Round': Go With Eldorado Gold
Generex: What Happens in India, Stays in India
Biotech Stock Mailbag: Generex, Part II
Biotech Stock Mailbag: Generex
MannKind's Diabetes Device Under More Clouds

MannKind Corporation to Hold 2010 Second Quarter Financial Results Conference Call on August 2, 2010

Posted on 07/26/10 at 6:15pm
VALENCIA, Calif.--(BUSINESS WIRE)-- MannKind Corporation (Nasdaq: MNKD) will release its 2010 second quarter financial results on Monday, August 2, 2010.
Click here to read the rest of the article

MannKind Corporation to Hold 2010 Second Quarter Financial Results

Posted on 07/26/10 at 5:00pm
VALENCIA, Calif.--(BUSINESS WIRE)-- MannKind Corporation (Nasdaq: MNKD) will release its 2010 second quarter financial results on Monday, August 2, 2010.
Click here to read the rest of the article

Late Pop Impressive 07-20-2010

Posted on 07/20/10 at 7:12pm
Cusick’s Corner
Click here to read the rest of the article

Are Earnings Weighing In? 07-20-2010

Posted on 07/20/10 at 2:45pm
Cusick’s Corner
Click here to read the rest of the article
Posted in

Mankind Surges On Acceptance Of Resubmitted Application For Afrezza

Posted on 07/20/10 at 11:20am
Shares of Mannkind Inc (NASDAQ: MNKD) are moving up after the US Food and Drug Administration accepted the company’s resubmitted application for the inhaled insulin product Afrezza.
Click here to read the rest of the article
Posted in

FDA Accepts AFREZZA Complete Response Resubmission and Sets Target Action Date

Posted on 07/20/10 at 9:16am
VALENCIA, Calif.--(BUSINESS WIRE)-- MannKind Corporation (NASDAQ: MNKD) today announced that it has submitted, and the U.S.
Click here to read the rest of the article

PennyOmega.com Announces Stock Alert on DARA, ORFG, MNKD, SNRY

Posted on 06/29/10 at 1:12pm
(via COMTEX News Network)-- PennyOmega tracks stocks daily and is pleased to offer its hot stock alerts. Investors can receive FREE Stock Alerts by visiting PennyOmega.com at the following link: http://www.PennyOmega.com.
Click here to read the rest of the article

AFREZZA™ Demonstrates Long-Term Efficacy in Controlling Blood Sugar Levels in Patients with Type 2 Diabetes

Posted on 06/28/10 at 6:33pm
ORLANDO, Fla.--(BUSINESS WIRE)-- AFREZZATM (insulin human [rDNA origin]) Inhalation Powder, a well-tolerated, investigational ultra rapid acting mealtime insulin, as part of a diabetes treatment regimen, provides long-term glucose control comparable to usual insulin therapy but with a significantly reduced incidence o
Click here to read the rest of the article

AFREZZA™ Suppresses Endogenous Glucose Production More Rapidly Than Currently Available Insulin Therapy

Posted on 06/26/10 at 10:20am
ORLANDO, Fla.--(BUSINESS WIRE)-- AFREZZATM (insulin human [rDNA origin]) Inhalation Powder, a well-tolerated, investigational ultra rapid acting mealtime insulin, provides more rapid suppression of endogenous glucose production (EGP) after a meal than the subcutaneously-injected insul
Click here to read the rest of the article